Abstract
In the diagnosis of autoimmune hepatitis type I (AIH‐I), the routine assay of indirect immunofluorescence (IFL), used for the detection of anti‐smooth muscle antibodies (ASMAs), has a low predictive value. On the other hand, the enzyme‐linked immunosorbent assay (ELISA), which detects anti‐cytoskeleton antibodies (ACTAs), presents contradictory results concerning their specific antigenic target. In this study, we first looked for the immunological properties (isotypes and antigenic targets) of autoantibodies in AIH‐I and two other control liver diseases: primary biliary cirrhosis (PBC) and viral hepatitis (VH), using ELISA based on cytoskeleton proteins: F‐actin, G‐actin, myosin, tropomyosin, troponin, desmin, vimentin, keratin, and an extract of HEp‐2 carcinoma cells. We also compared the diagnostic value of IFL and ELISA. In contrast to previous studies, we found that actin was not specific for AIH‐I. No autoantigen and no antibody class or subclass discriminated AIH‐I from the control diseases. IFL is more suitable for AIH‐I diagnosis, as 97% of AIH‐I sera but only 22% of PBC sera were ASMA‐positive. Additionally, 96% of ASMA‐positive, and all ASMA‐negative sera from all three liver diseases were ACTA‐positive. ASMA were mainly IgG, while >50% of ACTA also contained IgA and IgM. These data suggest that ACTAs recognize additional epitopes as compared to ASMAs, and they frequently occur in all liver diseases. © 2002 Wiley‐Liss, Inc.
Keywords: cytoskeleton proteins, primary biliary cirrhosis, autoimmune hepatitis type I, Ig classes and subclasses, HEp‐2 cells, indirect immuno‐fluorescence, ELISA, immunodiagnostics
REFERENCES
- 1. Whittingham S, Mackay IR. Smooth muscle autoantibodies In: Peter JB, Shoenfeld Y, editors. Autoantibodies. Amsterdam: Elsevier Science BV; 1996. p 767–773. [Google Scholar]
- 2. Abuaf N, Johanet C, Homberg JC. Autoantibodies in autoimmune chronic active hepatitis In: Krawitt E, Wiesner R, editors. Autoimmune liver diseases. New York: Raven Press, Ltd; 1991. p 93–109. [Google Scholar]
- 3. Bylund D, McHutchison J. Autoimmune liver diseases. Clin Lab Med 1997;17:483–497. [PubMed] [Google Scholar]
- 4. Toh BH. Smooth muscle autoantibodies and autoantigens. Clin Exp Immunol 1979;38:621–628. [PMC free article] [PubMed] [Google Scholar]
- 5. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB, Taswell HF, Homburger HA. Evidence against viruses as important causes of severe autoimmune hepatitis in the United States. J Hepatol 1993;18:342–352. [DOI] [PubMed] [Google Scholar]
- 6. Kurki P. Cytoskeleton antibodies In: Nishioka M, Toda G, Zeniya M, editors. Autoimmune hepatitis. Elsevier Science BV; 1994. p 185–198. [Google Scholar]
- 7. Nakamura RM, Bylund DJ. Diagnostic significance of autoantibodies in autoimmune chronic hepatitis. Clin Immunol Newsl 1991;11:161–167. [Google Scholar]
- 8. Bottazzo GF, Florin‐Christensen A, Fairfax A, Swana G, Donicah D, Groschel‐Stewart U. Classification of smooth muscle autoantibodies detected by immunofluorescence. J Clin Pathol 1976;29:403–410. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Gabbiani G, Ryan GB, Lamelin JP. Human smooth muscle autoantibody, its identification as antiactin antibody and a study of its binding to “nonmuscular” cells. Am J Pathol 1973;72:473–484. [PMC free article] [PubMed] [Google Scholar]
- 10. Lidman K, Biderfeld G, Fagraeus A, Norberg R, Torstensson R, Utter G. Anti‐actin specificity of human smooth muscle antibodies in chronic active hepatitis. Clin Exp Immunol 1976;24:266–272. [PMC free article] [PubMed] [Google Scholar]
- 11. Zauli D, Crespi C, Bianchi FB, Pisi E. Immunofluorescent detection of anti‐cytoskeleton antibodies using vinblastine‐treated mononuclear cells. J Immunol Methods 1985;85:77–82. [DOI] [PubMed] [Google Scholar]
- 12. Kurki P, Linder E, Miettinen A, Alfthan O. Smooth muscle antibodies of actin and non actin specificity. Clin Immunol Immunopathol 1978;9:443–453. [DOI] [PubMed] [Google Scholar]
- 13. Kurki P, Virtanen I. The detection of human antibodies against cytoskeletal components. J Immunol Methods 1984;67:209–223. [DOI] [PubMed] [Google Scholar]
- 14. Pedersen JS, Toh BH, Locarnini SA, Gust ID, Shyamala GNS. Autoantibody to intermediate filaments in viral hepatitis. Clin Immunol Immunopathol 1981;21:154–161. [DOI] [PubMed] [Google Scholar]
- 15. Takaki A, Sakaguchi K, Ogawa S, Kawamoto H, Tsuji T. Specificities and clinical significance of anti‐cytoskeleton antibodies in anti‐smooth muscle antibody positive patients with chronic liver disease C. Acta Med Okayama 1994;48:143–149. [DOI] [PubMed] [Google Scholar]
- 16. Dighiero G, Lymberi P, Monot C, Abuaf N. Sera with high levels of anti‐smooth muscle and anti‐mitochondrial antibodies frequently bind to cytoskeleton proteins. Clin Exp Immunol 1990;82:52–56. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Kurki P, Miettinen A, Linder E, Pikkarainen P, Vuoristo M, Salaspuro MP. Different types of smooth muscle antibodies in chronic active hepatitis and primary biliary cirrhosis: their diagnostic and prognostic significance. Gut 1980;21:878–884. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Bretherton E, Brown C, Pedersen JS, et al. ELISA assay for IgG autoantibody to G‐actin: comparison of chronic active hepatitis and acute viral hepatitis. Clin Exp Immunol 1983;51:611–616. [PMC free article] [PubMed] [Google Scholar]
- 19. Leibovitch L, George J, Levi Y, Bakimer R, Shoenfeld Y. Anti‐actin antibodies in sera from patients with autoimmune liver diseases and patients with carcinomas by ELISA. Immunol Lett 1995;48:129–132. [DOI] [PubMed] [Google Scholar]
- 20. Andersen P, Small JV, Andersen HK, Sobieszek A. Reactivity of smooth muscle antibodies with F‐ and G‐actin. Immunology 1979;37:705–709. [PMC free article] [PubMed] [Google Scholar]
- 21. Spudish JA, Watt S. The regulation of rabbit skeletal muscle contraction. J Biol Chem 1971;246:4866–4871. [PubMed] [Google Scholar]
- 22. Whalen RG, Butler‐Browne S, Gros F. Identification of a novel form of myosin light chain present in embryonic muscle tissue and cultured muscle cells. J Mol Biol 1978;126:415–431. [DOI] [PubMed] [Google Scholar]
- 23. Mappouras D, Philippou G, Haralambous S, Tzartos S, Balafas A. Antibodies to acetylcholinesterase cross‐reacting with thyroglobulin in myasthenia gravis and Graves' disease. Clin Exp Immunol 1995;100:336–343. [DOI] [PMC free article] [PubMed] [Google Scholar]